saxagliptin 5 MG Oral Tablet [Onglyza]
RxNorm concept 858040, branded drug (sbd). Prescribable name: onglyza 5 MG Oral Tablet.
- RxCUI
- 858040
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/858040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Onglyza (as sAXagliptin hydrochloride 5.58 MG) 5 MG Oral Tablet; Onglyza (as saxagliptin hydrochloride 5.58 MG) 5 MG Oral Tablet; sAXagliptin 5 MG Oral Tablet [Onglyza]
Related concepts
- saxagliptin 5 MG (SCDC, consists of)
- saxagliptin 5 MG [Onglyza] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Onglyza (BN, has ingredient)
- saxagliptin 5 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00310610530
- 00310610590
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 858040 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/858040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 858040. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.